2013/11/20 by Karl‐Heinz Kück, Pierre Bordachar, Martin Borggrefe +14 · 2 citations
Medicine · Neuroscience · #Cardiac pacing and defibrillation studies #Vagus Nerve Stimulation Research #Heart Rate Variability and Autonomic Control #Medicine #Heart failure #Intracardiac injection #Cardiology #Internal medicine #QRS complex #Observational study #Heart Rhythm #Sinus rhythm #Heartbeat #Randomized controlled trial #Supraventricular arrhythmia #Cardiac resynchronization therapy #Atrial fibrillation #Ejection fraction
paper · pdf · doi:10.1093/europace/eut311
openalex publication_date 2013/11/20 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Several new devices for the treatment of heart failure (HF) patients have been introduced and are increasingly used in clinical practice or are under clinical evaluation in either observational and/or randomized clinical trials. These devices include cardiac contractility modulation, spinal cord stimulation, carotid sinus nerve stimulation, cervical vagal stimulation, intracardiac atrioventricular nodal vagal stimulation, and implantable hemodynamic monitoring devices. This task force believes that an overview on these technologies is important. Special focus is given to patients with HF New York Heart Association Classes III and IV and narrow QRS complex, who represent the largest group in HF compared with patients with wide QRS complex. An overview on potential device options in addition to optimal medical therapy will be helpful for all physicians treating HF patients.